Serotonin Synthesis Inhibitor — Patent Landscape

Aggregated US Orange Book patent estate across every drug in the serotonin synthesis inhibitor class. 5 active patents protecting 1 drugs. First major cliff: 2027. Daily refresh.

1
Drugs in class
5
Active US patents
49/100
Avg vulnerability
—
Annual revenue covered

Originators

Cliff calendar — next 15 years

2
27
1
28
2
31

Drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
TELOTRISTAT ETIPRATE — 5 49 — 2027-12-11

Most attackable patents

Patent Drug Type Vuln Expiry
7968559 TELOTRISTAT ETIPRATE method of use 75 2027-12-11
8653094 TELOTRISTAT ETIPRATE method of use 75 2028-12-19
7709493 TELOTRISTAT ETIPRATE method of use 68 2031-02-28
7553840 TELOTRISTAT ETIPRATE composition of matter 17 2027-12-11
8193204 TELOTRISTAT ETIPRATE composition of matter 10 2031-02-27

Strongest defences

Patent Drug Type Vuln Expiry
8193204 TELOTRISTAT ETIPRATE composition of matter 10 2031-02-27
7553840 TELOTRISTAT ETIPRATE composition of matter 17 2027-12-11
7709493 TELOTRISTAT ETIPRATE method of use 68 2031-02-28
8653094 TELOTRISTAT ETIPRATE method of use 75 2028-12-19
7968559 TELOTRISTAT ETIPRATE method of use 75 2027-12-11

Related